Design Therapeutics (DSGN) Q1 2025 Earnings

10MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.27
-0.24
-0.22
-0.2

Details

Expected EPS
-0.266667
Actual EPS
-0.24
Surprise EPS
0.03
Surprise Percent
+10%

Description

Design Therapeutics (DSGN) has reported earnings of -0.24 per share for Q1 2025.

0 Comments

Share your thoughts